Status:
COMPLETED
Dried Blood Spots for SARS-CoV-2 Serology (COVID-19).
Lead Sponsor:
University Ghent
Conditions:
SARS-CoV-2 Acute Respiratory Disease
Eligibility:
All Genders
18+ years
Phase:
NA
Brief Summary
This study aims to validate dried blood spots (DBS) for SARS-CoV-2 (Severe Acute Respiratory Syndrome 2) antibody detection in elderly individuals.
Detailed Description
In the current SARS-CoV-2 pandemic, testing for SARS-CoV-2 specific antibodies is paramount to monitor immune responses in post-authorization vaccination and sero-epidemiology studies. However, large ...
Eligibility Criteria
Inclusion
- nursing home staff and residents
Exclusion
- Not applicable
Key Trial Info
Start Date :
August 1 2020
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
September 30 2020
Estimated Enrollment :
440 Patients enrolled
Trial Details
Trial ID
NCT04880122
Start Date
August 1 2020
End Date
September 30 2020
Last Update
May 10 2021
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Ghent University
Ghent, Oost-Vlaanderen, Belgium, 9000